trial

Tobacco Intensive Motivational and Estimate Risk

NCTId NCT03583203
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 230 (actual)
Sponsored by Hospital Universitario Reina Sofia de Cordoba
Primary completion 2018-12-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
230 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2018-07-12
Primary completion
2018-12-01
Eligibility
ALL · 40 Years · 70 Years

Interventions & indications

Drugs
personalized information about lung damage

Sponsors

Hospital Universitario Reina Sofia de CordobaLead Sponsor
Instituto de Salud Carlos IIICollaborator

Investigators

1
Fernando Sarramea Crespo, PhdPrincipal Investigator

Sites

1 total
Córdoba, Spain

Facts & assertions

4 sourced
Enrollment
230
Phase
NA
Primary Completion Date
2018-12-01
Status
COMPLETED
relationships
The graph out of here
drug
personalized information about lung damage
drug
lead_sponsor
Hospital Universitario Reina Sofia de Cordoba
company
collaborator
Instituto de Salud Carlos III
company
indication
Bipolar Disorder
indication
Pulmonary Disease, Chronic Obstructive
indication
Severe Mental Disorder
indication
investigator
Fernando Sarramea Crespo, Phd
person